Skip to main content

Table 1 Patient and genotype characteristics of 6p terminal and subterminal deletion subgroups

From: The phenotypic spectrum of terminal and subterminal 6p deletions based on a social media-derived cohort and literature review

Subgroupa

Cohort parent/literature

Sex female/male

Age in years; months

median (range)b

Deletion size in Mb

median (range)

No. of OMIM genes

range (median)

No. of HI-genesc

range (median)

Patient A

(n = 1)

1/0

Male

34;0

0.92

4

0

Terminal B

(n = 14)

2/12

13/1

14;0 (n = 13)

(2;1–53;0)

2.21

(1.68–2.8)

9–10

(9)

2

Terminal C

(n = 5)

2/3

2/3

2;3 (n = 5)

(0;10–20;0)

3.31

(3.24–3.81)

18–20

(20)

4

Terminal D

(n = 13)

3/10

7/6

5;0 (n = 12)

(0;3–15;7)

5.54

(4.74–6.79)

24–31

(28)

6–7

Terminal E

(n = 7)

2/5

4/2

2;0 (n = 3)

(0;1–2;4)

11.45

(7.81–22.31)

37–88

(55)

10–24

(11)

Total terminal

(n = 40)

10/30

26/13

5;8 (n = 34)

(0;1–53;0)

4.28

(0.92–22.31)

4–88

(22)

0–24

(5)

Subterminal S

(n = 19)

3/16

10/7

7;5 (n = 19)

(0;1–49;0)

1.31

(0.005–5.13)

1–27

(5)

1–6

(2)

Total terminal and subterminal (n = 59)

13/46

36/20

6;6 (n = 53)

(0;1–53)

3.24

(0.005–22.31)

1–88

(18)

0–24

(4)

  1. aFor more information on the division of subgroups, see “Participants and genotype characteristics” and Fig. 1
  2. bIf known, foetuses excluded
  3. cHI = haploinsufficiency
  4. HI-genes are defined as genes with a HI score of 0–10% or a pLI score ≥ 0.9